Photodynamic therapy enhances liposomal doxorubicin distribution in tumors during isolated perfusion of rodent lungs

European Surgical Research

Volumn 47, Issue 4, 2011, Pages 196-204

  Cheng, C ^a   Wang, Y ^a   Haouala, A ^a   Debefve, E ^b   Andrejevic Blant, S ^a   Krueger, T ^a   Gonzalez, M ^a   Ballini, J P ^b   Peters, S ^a   Decosterd, L ^a   Van Den Bergh, H ^b   Ris, H B ^a   Perentes, J Y ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b EPFL   (Switzerland)

Author keywords

Animal model; Experimental study; Isolated lung perfusion; Lung; Microcirculation

Indexed keywords

3 METHYLCHOLANTHRENE; DOXORUBICIN; LIPORUBICIN; UNCLASSIFIED DRUG; VERTEPORFIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER CONTROL; CONTROLLED STUDY; DOSIMETRY; DRUG DISTRIBUTION; DRUG UPTAKE; FLUORESCENCE MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; ISOLATED LUNG; LOW DRUG DOSE; LUNG BLOOD VESSEL; LUNG EDEMA; LUNG INTERSTITIUM; LUNG PARENCHYMA; LUNG PERFUSION; LUNG SARCOMA; MALE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; RODENT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOXORUBICIN; LIPOSOMES; LUNG; LUNG NEOPLASMS; MALE; MICROSCOPY, FLUORESCENCE; PERFUSION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RATS; RATS, INBRED F344; SARCOMA;

EID: 80053549475     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000330744     Document Type: Article

References (35)

1. Van Schil PE, Hendriks JM, van Putte BP, et al: Isolated lung perfusion and related techniques for the treatment of pulmonary metastases. Eur J Cardiothorac Surg 2008; 33: 486-495.
2. Johnston MR, Minchen RF, Dawson CA: Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg 1995; 110: 368-373.
3. Pass HI, Mew DJ, Kranda KC, et al: Isolated lung perfusion with tumor necrosis factor for pulmonary metastases. Ann Thorac Surg 1996; 61: 1609-1617. (Pubitemid 26179704)
4. Ratto GB, Toma S, Civalleri D, et al: Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas. J Thorac Cardiovasc Surg 1996; 112: 614-622. (Pubitemid 26347014)
5. Burt ME, Liu D, Abolhoda A, et al: Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trial. Ann Thorac Surg 2000; 69: 1542-1549. (Pubitemid 30434890)
6. Putnam JB: New and evolving treatment methods for pulmonary metastases. Semin Thorac Cardiovasc Surg 2002; 14: 49-56.
7. Schröder C, Fisher S, Pieck AC, et al: Technique and results of hyperthermic (41 degrees C) isolated lung perfusion with high-doses of cisplatin for the treatment of surgically relapsing or unresectable lung sarcoma metastasis. Eur J Cardiothorac Surg 2002; 22: 41-46. (Pubitemid 34743712)
8. Grootenboers M, Schramel F, van Boven WJ, et al: Re-evaluation of toxicity and long-term follow-up of isolated lung perfusion with melphalan in patients with resectable pulmonary metastases: a phase I and extension trial. Ann Thorac Surg 2007; 83: 1235-1236. (Pubitemid 46328808)
9. Minchin RF, Johnston MR, Aiken MA, et al: Pharmacokinetics of doxorubicin in isolated lungs of dogs and humans perfused in vivo. J Pharmacol Exp Ther 1984; 229: 193-198. (Pubitemid 14082931)
10. Weksler B, Schneider A, Bruce NG, Burt M: Isolated single lung perfusion in the rat: an experimental model. J Appl Physiol 1993; 74: 2736-2739. (Pubitemid 23201299)
11. Weksler B, Ng B, Lenert JT, Burt M: Isolated single-lung perfusion with doxorubicin is pharmacokinetically superior to intravenous injection. Ann Thorac Surg 1993,56: 209-214. (Pubitemid 23245125)
12. Weksler B, Ng B, Lenert JT, Burt ME: Isolated single-lung perfusion: a study of the optimal perfusate and other pharmacokinetic factors. Ann Thorac Surg 1995; 60: 624-629.
13. Abolhoda A, Brooks A, Nawata S, et al: Isolated lung perfusion with doxorubicin prolongs survival in a rodent model of pulmonary metastases. Ann Thorac Surg 1997; 64: 181-184. (Pubitemid 27313902)
14. Schrump DS, Zhai S, Nguyen DM, et al: Pharmacokinetics of paclitaxel administered by hyperthermic retrograde isolated lung perfusion techniques. J Thorac Cardiovasc Surg 2002; 123: 686-694. (Pubitemid 34535078)
15. Krueger T, Kuemmerle A, Andrejevic-Blant S, et al: Antegrade versus retrograde isolated lung perfusion: doxorubicin uptake and distribution in a sarcoma model. Ann Thorac Surg 2006; 82: 2024-2030.
16. Yan H, Cheng C, Haouala A, et al: Distribution of free and liposomal doxorubicin after isolated lung perfusion in a sarcoma model. Ann Thorac Surg 2008; 85: 1125-1132.
17. Gabizon AA: Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res 1992; 52: 891-896.
18. Cheng C, Haouala A, Krueger T, et al: Drug uptake in a rodent sarcoma model after intravenous injection or isolated lung perfusion of free/liposomal doxorubicin. Interact J Cardiovasc Thorac Surg 2009; 8: 635-638.
19. Jain RK: Normalisation of tumor vasculature: an emerging concept in antiangiogenetic therapy. Science 2005; 307: 58-62. (Pubitemid 40093472)
20. Henderson BW, Gollnick SO: Mechanistic principles of photodynamic therapy; in Vo- Dinh (ed): Biomedical Photonics Handbook, pp 36-1-36-27. Boca Raton, CRC Press, 2003.
21. Fingar VH: Vascular effects of photodynamic therapy. J Clin Laser Med Surg 1996; 14: 323-328. (Pubitemid 26405724)
22. Debefve E, Pegaz B, van den Bergh H, et al: Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model. Angiogenesis 2008; 11: 235-243.
23. Snyder JW, Greco WR, Bellnier DA, Vaughan L, Henderson BW: Photodynamic therapy: a means to enhanced drug delivery to tumors. Cancer Res 2003; 63: 8126-8131. (Pubitemid 37549458)
24. Cheng C, Debefve E, Haouala A, et al: Photodynamic therapy selectively enhances liposomal doxorubicin uptake in sarcoma tumors to rodent lungs. Lasers Surg Med 2010; 42: 391-399.
25. Krueger T, Pan Y, Tran N, et al: Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats. Lasers Surg Med 2005; 37: 271-277. (Pubitemid 41598955)
26. Chin DL, Lum BL, Sikic BI: Rapid determination of pegylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet visible high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 79: 259-269. (Pubitemid 35279453)
27. Perentes JY, McKee TD, Ley CD, et al: In vivo imaging of extracellular matrix remodeling by tumor-associated fibroblasts. Nat Methods 2009; 6: 143-145.
28. Perentes JY, Kirkpatrick ND, Nagano S, et al: Cancer cell-associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumors. Cancer Res 2011; 71: 4527-4538.
29. Bessler N, Committee VSW: Verteporphin therapy in age-related macular degeneration: an open-label multicenter photodynamic study of 4435 patients. Retina 2004; 20: 3-7.
30. Opitz I, Krueger T, Pan Y, et al: Preclinical comparison of mTHPC and verteporfin for intracavitary photodynamic therapy of malignant pleural mesothelioma. Eur Surg Res 2006; 38: 333-339. (Pubitemid 44154682)
31. Debefve E, Cheng C, Schaefer S, et al: Photodynamic therapy induces selective extravasation of macromolecules: insights using intravital microscopy. J Photochem Photobiol B 2010; 98: 69-76.
32. Krueger T, Kuemmerle A, Kosinski M, et al: Cytostatic lung perfusion results in heterogeneous spatial regional blood flow and drug distribution: evaluation of different cytostatic lung perfusion techniques in a porcine model. J Thorac Cardiovasc Surg 2006; 132: 304-311. (Pubitemid 44092834)
33. Tong RT, Boucher Y, Kozin SV, et al: Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res 2004; 64: 3731-3736. (Pubitemid 38697278)
34. Winkler F, Kozin SV, Tong RT, et al: Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin- 1, and matrix metalloproteinases. Cancer Cell 2004; 6: 553-563. (Pubitemid 40017699)
35. Willett CG, Boucher Y, di Tomaso E, et al: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 2004; 10: 145-147. (Pubitemid 38524883)